Clorox Director Buys $429K in Stock Near 52-Week Lows Amidst Recent Financial Headwinds
Summary
A director of Clorox purchased over $429,000 worth of common stock on the open market, signaling confidence as the company's shares trade near 52-week lows and following recent negative financial news.
Key Events
-
Director Purchases Shares
Pierre R. Breber, a director, acquired 5,000 shares of Clorox common stock through an open market purchase.
-
Significant Investment
The purchase totaled $429,124, reflecting a notable personal investment by the director.
-
Timing Near 52-Week Lows
The transaction occurred while Clorox's stock is trading near its 52-week low, potentially indicating a belief that the stock is undervalued.
-
Confidence Amidst Headwinds
This insider buy follows recent negative financial news, including a lowered earnings forecast and a concerning 10-Q, suggesting conviction in the company's future.
Analysis
Pierre R. Breber, a director at Clorox, made a significant open market purchase of 5,000 shares for $429,124. This transaction is notable given that Clorox's stock is currently trading near its 52-week low and follows a recent 10-Q filing that reported declining sales, increased debt, and a lowered earnings forecast. An insider buying shares under these circumstances suggests a belief in the company's long-term value and a potential turnaround, despite recent challenges.
At the time of this filing, CLX was trading at $86.57 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $10.4B. The 52-week trading range was $84.70 to $139.35. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.